Skip to main content
Toggle navigation
Login
Search
Home
Program Book
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Back
Favorite
Like
Tweet
Irene Arias
Poster(s):
(353) Talazoparib Plus Enzalutamide in Metastatic Castration-Resistant Prostate Cancer: Safety Analyses From the Randomized, Placebo-Controlled, Phase 3 TALAPRO-2 Study
Wednesday, April 3, 2024
5:00 PM – 7:00 PM
ET
(358) Exposure-Safety Analyses of Talazoparib in Combination With Enzalutamide in Patients with Metastatic Castration-Resistant Prostate Cancer (mCRPC) in TALAPRO-2 Trial
Wednesday, April 3, 2024
5:00 PM – 7:00 PM
ET